Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
5(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
10%
Ph not_applicable
9
90%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

10

all time

Status Distribution
Active(5)
Completed(3)
Other(2)

Detailed Status

Recruiting5
Completed3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
5
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (10.0%)
N/A9 (90.0%)

Trials by Status

unknown220%
recruiting550%
completed330%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10